WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA approves first systemic treatment for alopecia areata 13 June 2022
FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain 19 May 2022
FDA limits use of Janssen COVID-19 vaccine to certain individuals 06 May 2022
FDA approves first generic of Symbicort to treat asthma and COPD 15 March 2022
FDA approves treatment for wider range of patients with heart failure 24 February 2022
FDA takes key action by approving second COVID-19 vaccine 31 January 2022
FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults 27 December 2021
FDA authorizes first oral antiviral for treatment of COVID-19 22 December 2021
FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16- and 17-year-olds 09 December 2021
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age 29 October 2021
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases 28 October 2021
FDA takes additional actions on the use of a booster dose for COVID-19 vaccines 21 October 2021
FDA awards 11 grants to clinical trials to develop new medical products for rare disease treatments 14 October 2021
FDA approves innovative treatment for pediatric patients with congenital athymia 08 October 2021
FDA authorizes software that can help identify prostate cancer 21 September 2021
FDA advances data, IT modernization efforts with new office of digital transformation 15 September 2021
FDA approves first COVID-19 vaccine 24 August 2021
FDA approves new treatment for Pompe disease 06 August 2021
FDA approves first interchangeable biosimilar insulin product for treatment of diabetes 29 July 2021
FDA approves first oral blood thinning medication for children 22 June 2021
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Business & Industry

  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe
  • Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design

Research & Development

  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19
  • Scientists develop new biomimetic formulation for treating glioblastoma
  • SARS-CoV-2 hijacks nanotubes between neurons to infect them

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. FDA
  4. FDA approves treatment for wider range of patients with heart failure

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.